Ketorolac Tromethamine Injection Shortage: Current Availability and Manufacturer Updates
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Supply of Ketorolac Tromethamine Injection is currently limited, with mixed availability reported across several major pharmaceutical manufacturers.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on February 11, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Drug Shortages — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA drug-shortage notice is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (drug-shortage, fda, medication, Ketorolac Tromethamine) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What's in Shortage
Ketorolac Tromethamine Injection (Brand Name: KETOROLAC TROMETHAMINE) is currently listed as in shortage. This medication is used within the Analgesia/Addiction therapeutic category. The shortage affects various strengths and presentations of the injection form. This shortage was first posted on March 26, 2018, and was last updated on February 3, 2026.
Which Manufacturers Are Affected
Availability varies significantly by manufacturer and specific product presentation:
Sagent Pharmaceuticals (866-625-1618):
- 30 mg/1 mL (NDC 25021-701-01): Available
- 15 mg/1 mL (NDC 25021-700-01): Available
- 30 mg/1 mL (NDC 25021-701-02): Available
Baxter Healthcare (888-229-0001):
- 30 mg/1 mL (NDC 0338-0072-25): Available
- 15 mg/1 mL (NDC 0338-0069-10): Available
Fresenius Kabi USA, LLC (888-386-1300):
- 15 mg/1 mL (NDC 63323-161-01): Available (Check wholesaler inventory)
- 30 mg/1 mL (NDC 63323-162-02): Available (Check wholesaler inventory)
- 30 mg/1 mL (NDC 76045-104-10): Unavailable
- 60 mg/2 mL (NDC 76045-105-20): Unavailable
- 15 mg/1 mL (NDC 76045-107-10): Unavailable
- 30 mg/1 mL (NDC 63323-162-01): Unavailable; next release date not available.
Why There's a Shortage
No specific reason for the shortage was provided in the current FDA report.
What Patients Should Do
If you are a patient who requires Ketorolac Tromethamine Injection, please consider the following steps:
- Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication availability.
- Speak with your pharmacist: They can check current wholesaler inventory and may have information on which specific presentations are in stock.
- Contact manufacturers: You may use the contact numbers provided above to inquire about the most recent availability status for specific NDC numbers.
Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or pharmacist for medical advice and guidance regarding medication changes or alternatives.
Source
Information provided by the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.
What is this FDA drug-shortage notice about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more Drug Shortages updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category